Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients (TITRATION)
Read time: 1 mins
Last updated:12th Aug 2013
The purpose of this study is to assess the safety and tolerability of initiating LCZ696 in heart failure patients with reduced ejection fraction (HF-rEF) using conservative (reaching target dose over 6 weeks) and condensed (reaching target dose over 3 weeks) up-titration regimens.
|Study start date||2013-08-12|